Monitor for future prospectus supplements that will disclose the specific terms of any offering, including security type, price, and size. The 'Baby Shelf' limitation suggests any single offering will likely be under $25 million, but the large shelf size indicates a potential for multiple capital raises, which could lead to significant shareholder dilution over time.
PDSB drugs
PDSB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 27 $0.9300entry
- T+1 · 7mo ago +16.13%α +16.61% · $1.08
- T+5 · 7mo ago +7.53%α +7.13% · $1.00
- T+20 · 6mo ago +18.28%α +13.32% · $1.10
- T+60 · 4mo ago −23.06%α −27.84% · $0.7155
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
PDS Biotechnology Corp filed an S-3/A shelf registration statement, authorizing the potential issuance of up to $200 million in securities, including common stock, preferred stock, debt securities, warrants, units, and rights. This filing updates market price information and removes a prior $20 million ATM offering, signaling the company's intent to access capital markets opportunistically in the future.
Key Financial Metrics
Key Facts
- PDSB filed an S-3/A shelf registration statement with an aggregate offering price of $200 million.
- The filing removes a prior $20 million ATM offering agreement.
- Proceeds are intended for product development, commercialization, and general corporate purposes.
- The company has a market cap of $50 million, making the $200 million shelf size significant at 400% of market cap.
- The public float is $73.99 million, and the company is subject to the 'Baby Shelf' limitation, restricting offerings to one-third of the public float ($24.66 million) in any 12-month period.
Financial Impact
Potential issuance of up to $200 million in securities, representing 400% of the current $50 million market cap.
Risk Factors
- Significant shareholder dilution if common stock is issued.
- Potential for multiple capital raises over the shelf's life, increasing dilution risk.
- Downward pressure on stock price if offerings are perceived as dilutive or opportunistic.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001140361-26-016756 |
| Document: ny20071147x1_ex107.htm | 0001140361-26-016756 |
| Document: ny20071147x1_ex5-1.htm | 0001140361-26-016756 |
| Document: ny20071147x1_ex23-1.htm | 0001140361-26-016756 |
| Document: 0001140361-26-016756-index-headers.html | 0001140361-26-016756 |
| Document: 0001140361-26-016756-index.html | 0001140361-26-016756 |
| Document: 0001140361-26-016756.txt | 0001140361-26-016756 |
Track record
28 reports on PDSB
7 of 14 bullish or bearish reports moved the stock their way by T+20. Best: +71.95% at T+20 after the Jul 22, 2026 report. 11 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
- Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
- Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
- Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
- Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers